Strontium ranelate is a drug to treat osteoarthrosis
To prevent disease progression in patients with osteoarthosis (OA) remains a challenging problem. Despite the proposed drug, non-drug, and surgical treatments for OA, there is a clinical need for medications that have a structure-modifying effect and are able to delay or prevent cartilage degradatio...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-03-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/471 |
id |
doaj-004ef4d77c134c6da2873d4064f1f2cb |
---|---|
record_format |
Article |
spelling |
doaj-004ef4d77c134c6da2873d4064f1f2cb2021-07-29T09:00:08ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2013-03-0171778110.14412/1996-7012-2013-23731776Strontium ranelate is a drug to treat osteoarthrosisOksana Anatolyevna NikitinskayaTo prevent disease progression in patients with osteoarthosis (OA) remains a challenging problem. Despite the proposed drug, non-drug, and surgical treatments for OA, there is a clinical need for medications that have a structure-modifying effect and are able to delay or prevent cartilage degradation and to alleviate the clinical manifestations of the disease. A 3-year international randomized clinical trial has demonstrated strong evidence for the symptomand structure-modifying effect of strontium ranelate in female and male patients with clinical primary knee OA. The clinical use of the drug opens up new prospects for preventing the progression of the disease in patients with knee and hip OA.https://mrj.ima-press.net/mrj/article/view/471osteoporosisstrontium ranelatestructure-modifying drugs for osteoarthrosis treatment |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
Oksana Anatolyevna Nikitinskaya |
spellingShingle |
Oksana Anatolyevna Nikitinskaya Strontium ranelate is a drug to treat osteoarthrosis Современная ревматология osteoporosis strontium ranelate structure-modifying drugs for osteoarthrosis treatment |
author_facet |
Oksana Anatolyevna Nikitinskaya |
author_sort |
Oksana Anatolyevna Nikitinskaya |
title |
Strontium ranelate is a drug to treat osteoarthrosis |
title_short |
Strontium ranelate is a drug to treat osteoarthrosis |
title_full |
Strontium ranelate is a drug to treat osteoarthrosis |
title_fullStr |
Strontium ranelate is a drug to treat osteoarthrosis |
title_full_unstemmed |
Strontium ranelate is a drug to treat osteoarthrosis |
title_sort |
strontium ranelate is a drug to treat osteoarthrosis |
publisher |
IMA-PRESS LLC |
series |
Современная ревматология |
issn |
1996-7012 2310-158X |
publishDate |
2013-03-01 |
description |
To prevent disease progression in patients with osteoarthosis (OA) remains a challenging problem. Despite the proposed drug, non-drug, and surgical treatments for OA, there is a clinical need for medications that have a structure-modifying effect and are able to delay or prevent cartilage degradation and to alleviate the clinical manifestations of the disease. A 3-year international randomized clinical trial has demonstrated strong evidence for the symptomand structure-modifying effect of strontium ranelate in female and male patients with clinical primary knee OA. The clinical use of the drug opens up new prospects for preventing the progression of the disease in patients with knee and hip OA. |
topic |
osteoporosis strontium ranelate structure-modifying drugs for osteoarthrosis treatment |
url |
https://mrj.ima-press.net/mrj/article/view/471 |
work_keys_str_mv |
AT oksanaanatolyevnanikitinskaya strontiumranelateisadrugtotreatosteoarthrosis |
_version_ |
1721250366203363328 |